ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstracts tagged "joint damage"

  • Abstract Number: 2300 • 2017 ACR/ARHP Annual Meeting

    Predictive Value of Magnetic Resonance Imaging in Patients with Juvenile Idiopathic Arthritis in Clinical Remission

    Clara Malattia1, Marta Mazzoni Sr.2, Stefania Viola Sr.2, Angela Pistorio3, Francesca Magnaguagno4, Alessia Urro Jr.2, Angelo Ravelli5 and Alberto Martini6, 1Pediatria2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, 2Pediatria 2 Reumatologia, Istituto Giannina Gaslini, Genova, Italy, 3Istituto Giannina Gaslini - Pediatria II, Reumatologia - PRINTO, Genoa, Italy, 4UO Radiologia, Istituto Giannina Gaslini, Genoa, Italy, 5University of Genova, IRCCS Istituto Giannina Gaslini, Genova, Italy, 6Istituto Giannina Gaslini, Genoa, Italy

    Background/Purpose: MRI studies on RA revealed that subclinical synovitis is common in patients in clinical remission and it is responsible for structural damage progression. MRI-detected…
  • Abstract Number: 2458 • 2017 ACR/ARHP Annual Meeting

    Tocilizumab Inhibits Progression of Erosive Joint Damage in Early Rheumatoid Arthritis More Effectively Than Step-up Methotrexate Therapy

    Xavier M Teitsma1, Johannes WG Jacobs1, Paco MJ Welsing2, Attila Pethö-Schramm3, Michelle EA Borm4, Jacob M. van Laar5, Floris PJ Lafeber5 and Johannes W.J. Bijlsma2, 1Department of Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 2Rheumatology and Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands, 3F. Hoffmann-La Roche, Basel, Switzerland, 4Beneluxlaan 2a, Roche Nederland BV, Woerden, Netherlands, 5Rheumatology & Clinical Immunology, University Medical Center Utrecht, Utrecht, Netherlands

    Background/Purpose: In early rheumatoid arthritis (RA), starting therapy as soon as possible is important to reduce disease activity and preserve the joints. With application of…
  • Abstract Number: 382 • 2017 ACR/ARHP Annual Meeting

    Radiological Features Identified in the Hands of Children with Down Syndrome and Inflammatory Arthritis

    Charlene Foley1, Emma Jane Mac Dermott1, Aisling Snow2 and Orla G Killeen1, 1National Centre for Paediatric Rheumatology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland, 2Radiology, Our Lady's Children's Hospital Crumlin, Dublin, Ireland

    Background/Purpose: Down’s Arthritis (DA) is an inflammatory joint condition affecting children with Down syndrome (DS). It is 18-21 times more common than JIA in the…
  • Abstract Number: 429 • 2017 ACR/ARHP Annual Meeting

    Repair of Joint Damage Is Rare in Newly Diagnosed Rheumatoid Arthritis Patients and Appears Not to Relate to Previous Suppression of Inflammation

    Joy A. van der Pol1, Gulsah Akdemir1, Marianne van den Broek1, Linda Dirven1, Pit J.S.M. Kerstens2, Willem F. Lems3, Iris M. Markusse1, Cornelia F Allaart1 and Tom W.J. Huizinga1, 1Department of Rheumatology, LUMC, Leiden, Netherlands, Leiden, Netherlands, 2Department of Rheumatology, Reade, Amsterdam, Netherlands, 3Department of Rheumatology, VU Medical Center, Amsterdam, Netherlands, Amsterdam, Netherlands

    Background/Purpose: Joint damage in RA is thought to be irreparable. We hypothesized that in patients in whom inflammation is persistently well suppressed, repair may be…
  • Abstract Number: 436 • 2017 ACR/ARHP Annual Meeting

    Baseline Anemia As a Predictor of Radiographic Progression in Tofacitinib-Treated Rheumatoid Arthritis Patients: Post Hoc Analyses from Two Phase 3 Trials

    Burkhard Moeller1, Axel Finckh2, Godehard Scholz1, Harry Shi3, Carol A Connell4 and Sander Strengholt5, 1Department for Rheumatology, Immunology and Allergology, University Hospital of Bern, Bern, Switzerland, 2University Hospital of Geneva, Geneva, Switzerland, 3Pfizer Inc, Collegeville, PA, 4Pfizer Inc, Groton, CT, 5Pfizer Inc, Capelle aan den IJssel, Netherlands

    Background/Purpose: Anemia in patients with rheumatoid arthritis (RA) can help to identify those with more rapid erosive disease.1,2 Tofacitinib is an oral Janus kinase inhibitor…
  • Abstract Number: 451 • 2017 ACR/ARHP Annual Meeting

    A Matrix Risk Model for Prediction of Radiographic Progression in Early Rheumatoid Arthritis Based on Treatment Response at 3 Months

    Pooneh S. Akhavan1, Daming Li1, Sahar Tabatabvakili1 and Edward C. Keystone2, 1Mount Sinai Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada

    Background/Purpose: The present study aimed to develop a matix to predict risk of radiographic progression in patients with early rheumatoid arthritis. The focus of this…
  • Abstract Number: 945 • 2016 ACR/ARHP Annual Meeting

    When and Where Musculoskeletal Ultrasound Might Replace Magnetic Resonance in the Assessment of Patients with Juvenile Idiopathic Arthritis?

    Stefano Lanni1, Francesca Magnaguagno2, Erica Ricci3, Angela Pistorio4, Cecilia Bava1, Alberto Martini5 and Clara Malattia6, 1Pediatria 2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy, 2UO Radiologia, Istituto Giannina Gaslini, Genoa, Italy, 3Istituto G. Gaslini, Pediatria 2 -Reumatologia, genova, Italy, 4Pediatria II, Reumatologia, PRINTO, Istituto Giannina Gaslini, Genoa, Italy, 5PRINTO-IRCCS, Genova, Italy, 6Pediatria2 Reumatologia, Istituto Giannina Gaslini, Genoa, Italy

    Background/Purpose: Magnetic resonance imaging (MRI) is the most attractive imaging modality for the investigation of patients with juvenile arthritis (JIA). Musculoskeletal ultrasound (MSUS) has intuitive…
  • Abstract Number: 1111 • 2016 ACR/ARHP Annual Meeting

    Huntingtin Interactin Protein 1 (HIP1) Regulates Receptor Tyrosine Kinases Mediated Activity and Cell Invasiness in Fibroblast-like Synoviocytes

    Teresina Laragione, Nasim Azizgolshani, Carolyn Harris, Erjing Gao and Percio Gulko, Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY

    Background/Purpose: Huntingtin-interacting protein 1 (Hip1) is a new arthritis severity gene recently identified in the Pristane and Collagen-induced arthritis (PIA, CIA) quantitative trait locus Cia25/Pia42…
  • Abstract Number: 1791 • 2016 ACR/ARHP Annual Meeting

    Loss of Elbow Hyperextension in Females with Early Rheumatologic Disease Was Common in Systemic Lupus Erythematosus and Rheumatoid Arthritis but Rare in Fibromyalgia

    John P. Case1, Heidi Tucker2 and Congbin Wang3, 1Internal Medicine/Rheumatology, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL, 2Rush Medical College, Chicago, IL, 3Internal medicine, John H. Stroger, Jr. Hospital of Cook County, Chicago, IL

    Background/Purpose:   The elbow extension angle (ELB) is commonly given as 180o although most healthy females exhibit hyperextension(1).  The loss of hyperextension (LOH) in a…
  • Abstract Number: 2489 • 2016 ACR/ARHP Annual Meeting

    Joint Damage Appears As Severe As Inflammation According to Physician Visual Analog Scales in Patients with Rheumatoid Arthritis Regardless of Disease Severity at 2 Sites, Which May Limit Results of a Treat-to-Target Strategy

    Theodore Pincus1, Isabel Castrejón1, Kathryn Gibson2 and Joel Block3, 1Rheumatology, Rush University Medical Center, Chicago, IL, 2Rheumatology, Liverpool Hospital and University of New South Wales, Liverpool, Australia, 3Division of Rheumatology, Rush University Medical Center, Chicago, IL

    Background/Purpose: A physician estimate of global status (DOCGL) on a 0-10 visual analog scale (VAS) was developed initially to assess inflammation in patients with rheumatoid…
  • Abstract Number: 3124 • 2016 ACR/ARHP Annual Meeting

    Huntingtin Interacting Protein 1 (Hip1) Is a New Arthritis Severity Gene

    Teresina Laragione1, Percio Gulko1 and Max Brenner2, 1Medicine/Rheumatology, Icahn School of Medicine at Mount Sinai, New York, NY, 2Feinstein Institute for Medical Research, Manhasset, NY

    Background/Purpose:  Cia25/Pia42 is an arthritis severity and joint damage quantitative trait locus on rat chromosome 12 previously identified in an intercross between MHC identical but…
  • Abstract Number: 3157 • 2016 ACR/ARHP Annual Meeting

    The Association Between Sonographic Enthesitis and Radiographic Damage in Psoriatic Arthritis

    Ari Polachek1, Dafna D Gladman2, Richard J. Cook3, Vinod Chandran4 and Lihi Eder5, 1Rheumatology, University of Toronto, Toronto Western Hospital, Toronto, ON, Canada, 2University of Toronto, Toronto, ON, Canada, 3Statistics and Actuarial Science, University of Waterloo, Waterloo, ON, Canada, 4Rheumatology, University of Toronto, Toronto, ON, Canada, 5Medicine, University of Toronto, Women's College Hospital, Toronto, ON, Canada

    Background/Purpose: Enthesitis is a common clinical finding and a key pathogenic feature in psoriatic arthritis (PsA). Ultrasound is emerging as a preferred method to assess…
  • Abstract Number: 1305 • 2015 ACR/ARHP Annual Meeting

    Prevalence of MR-Detected Ramris-Defined Erosions in the General Population

    L. Mangnus1, H.W. van Steenbergen2, M. Reijnierse3 and A.H.M. van der Helm- van Mil1, 1Rheumatology, Leiden University Medical Center, Leiden, Netherlands, 2Leiden University Medical Center, Leiden, Netherlands, 3Radiology, Leiden University Medical Center, Leiden, Netherlands

    Background/Purpose: The diagnostic value of Magnetic Resonance (MR) imaging for Rheumatoid Arthritis (RA) is undetermined. The main value of MR is its sensitive depiction of…
  • Abstract Number: 1307 • 2015 ACR/ARHP Annual Meeting

    Does Computerized Segmentation of Early Erosions on Magnetic Resonance Imaging Predict Functional Ability in Rheumatoid Arthritis?

    Matthew Jessome1, Michael Tomizza1, Karen A. Beattie2, William G. Bensen2, Raja Bobba2, Alfred Cividino2, Patrick D. Emond2, Chris Gordon2, Lawrence Hart2, George Ioannidis2, Maggie Larche2, Arthur Lau3, Ruben Tavares2, Stephen Tytus2 and Jonathan D. Adachi2, 1McMaster University, Hamilton, ON, Canada, 2St Joseph's Healthcare Hamilton, Hamilton, ON, Canada, 3Division of Rheumatology, McMaster University, Hamilton, ON, Canada

    Background/Purpose: Functional ability of rheumatoid arthritis (RA) patients is reduced by both acute (inflammatory) and chronic (joint damage) disease manifestations. However, the impact of early…
  • Abstract Number: 1325 • 2015 ACR/ARHP Annual Meeting

    Age Effects Joint Space Narrowing in Early Active Rheumatoid Arthritis Patients

    Xanthe M.E. Matthijssen1, Gülsah Akdemir1, Iris M. Markusse2, Yvonne P. Goekoop-Ruiterman3, K. Huub Han4, Annekoos L. Huidekoper5, Pit J.S.M. Kerstens6, Willem F. Lems7, T. W. J. Huizinga1 and Cornelia F. Allaart1, 1Rheumatology, LUMC, Leiden, Netherlands, 2LUMC, Leiden, Netherlands, 3Rheumatology, HAGA hospital, The Hague, Netherlands, 4Rheumatology, Maasstad hospital, Rotterdam, Netherlands, 5Rheumatology, Bronovo hospital, The Hague, Netherlands, 6Department of Rheumatology, Reade, Amsterdam, Netherlands, 7Rheumatology, Amsterdam Rheumatology and immunology Center, VU University medical center, Amsterdam, Netherlands

    Background/Purpose: Joint space narrowing (JSN) and erosions are the major radiologic markers of radiographic progression in rheumatoid arthritis (RA), as scored by the Sharp/van der…
  • « Previous Page
  • 1
  • 2
  • 3
  • 4
  • Next Page »
Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology